Kineta, Inc.
$0.57-30.77%($-0.26)
TickerSpark Score
50/100
100
Valuation
60
Profitability
10
Growth
48
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KA research report →
52-Week Range5% of range
Low $0.33
Current $0.57
High $5.39
Companykinetabio.com
Kineta, Inc. , a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners.
- CEO
- Craig W. Philips
- IPO
- 2016
- Employees
- 11
- HQ
- Seattle, WA, US
Price Chart
-82.96% · this period
Valuation
- Market Cap
- $7.05M
- P/E
- -2.24
- P/S
- 1.62
- P/B
- -0.56
- EV/EBITDA
- -1.91
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 162.93%
- Op Margin
- -52.72%
- Net Margin
- -76.35%
- ROE
- 26.26%
- ROIC
- 18.20%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-17,132,000 · -21.51%
- EPS
- $-1.42 · -10.94%
- Op Income
- $-13,532,000
- FCF YoY
- 28.64%
Performance & Tape
- 52W High
- $5.39
- 52W Low
- $0.33
- 50D MA
- $0.65
- 200D MA
- $1.12
- Beta
- 0.57
- Avg Volume
- 504.10K
Get TickerSpark's AI analysis on KA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 4, 24 | Peters Richard | other | 12,500 |
| Sep 4, 24 | Iadonato Shawn | other | 12,500 |
| Sep 4, 24 | Foote Marion R | other | 12,500 |
| Sep 4, 24 | Dylla Scott J. | other | 12,500 |
| Sep 4, 24 | Drapkin Kimberlee C | other | 12,500 |
| Sep 4, 24 | Bartoszek Raymond J. | other | 12,500 |
| Sep 4, 24 | Arkowitz David | other | 12,500 |
| May 1, 24 | Bartoszek Raymond J. | other | 903,995 |
| Apr 14, 24 | Iadonato Shawn | other | 225,000 |
| Apr 14, 24 | PHILIPS CRAIG W. | other | 225,000 |
Our KA Coverage
We haven't published any research on KA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KA Report →Similar Companies
FRTX-0.53%
Fresh Tracks Therapeutics, Inc.
$0.94
BIOR+0.00%
Biora Therapeutics, Inc.
$0.22
OMGA+0.00%
Omega Therapeutics, Inc.
$0.14
TSBX+0.00%
Turnstone Biologics Corp.
$0.35
TVRD+3.77%
Tvardi Therapeutics, Inc.
$3.85
CSCI+0.00%
COSCIENS Biopharma Inc.
$2.72
ENTO-5.00%
Entero Therapeutics, Inc.
$2.85
TCDA+0.00%
Tricida, Inc.
$0.11